Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: OTJR (Thorofare N J). 2023 Feb 9;43(4):702–709. doi: 10.1177/15394492231151887

Table 1.

Participant characteristics

Treatment group (n=6) Control group (n=6) p
Age mean (SD) in years 61 (10) 64 (8) 0.73
Male/female 5/1 2/4 0.24
Ischemic/hemorrhagic stroke 5/1 6/0 1.00
Time since stroke range in years 1-16 1-6 0.24
Fugl-Meyer Assessment Upper Extremity Score mean (SD) 45 (9) 51 (7) 0.59